Project Nightlight: Efficacy and System Acceptance of Dinner/Night vs. 24hr Closed Loop Control

Completed · Not applicable

Conditions studied: Diabetes Mellitus, Type 1

In brief

The purpose of this study is to use an investigational type of technology called Closed-Loop Control (CLC) Medical Platform System to help control blood sugar in people with type 1 diabetes mellitus in a home setting.

Key facts

Study ID

NCT02679287

Run by

University of Virginia

People needed

103

Starts

2016-02-01

Expected to finish

2019-04-01

Last updated by the study team

2020-06-09

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• type 1 diabetes for at least one year
• using insulin for at least 1 year
• an insulin pump for at least 6 months
• willingness to switch to lispro (Humalog) or aspart (Novolog) if using glulisine (Apidra).

You may not qualify if…

• a medical condition or being been treated with medications that might interfere with the study

Where it is running

• University of Virginia Center for Diabetes Technology — Charlottesville, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.